DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 90 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $474,008 | +47.3% | 30,134 | +51.1% | 0.00% | 0.0% |
| Q4 2023 | $321,745 | +107.9% | 19,947 | +99.2% | 0.00% | 0.0% |
| Q1 2023 | $154,732 | -86.5% | 10,015 | -70.2% | 0.00% | -75.0% |
| Q3 2021 | $1,143,000 | -28.7% | 33,639 | -23.2% | 0.00% | -33.3% |
| Q2 2021 | $1,603,000 | -59.8% | 43,794 | -50.7% | 0.01% | -66.7% |
| Q1 2021 | $3,985,000 | -48.9% | 88,866 | -35.0% | 0.02% | -47.1% |
| Q4 2020 | $7,806,000 | -0.4% | 136,776 | -10.5% | 0.03% | +9.7% |
| Q3 2020 | $7,840,000 | +0.2% | 152,837 | +16.6% | 0.03% | -20.5% |
| Q2 2020 | $7,827,000 | +315.2% | 131,075 | +186.3% | 0.04% | +225.0% |
| Q1 2020 | $1,885,000 | -43.3% | 45,786 | -14.3% | 0.01% | +9.1% |
| Q4 2019 | $3,326,000 | +208.2% | 53,433 | +68.0% | 0.01% | +175.0% |
| Q3 2019 | $1,079,000 | +838.3% | 31,800 | +983.8% | 0.00% | – |
| Q2 2018 | $115,000 | – | 2,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
| Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
| BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
| Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
| ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
| Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
| Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
| Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
| Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |